BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16364698)

  • 1. Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection.
    Beumer JH; Joseph E; Egorin MJ; Covey JM; Eiseman JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):147-55. PubMed ID: 16364698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mass balance and disposition study of the DNA methyltransferase inhibitor zebularine (NSC 309132) and three of its metabolites in mice.
    Beumer JH; Joseph E; Egorin MJ; Parker RS; D'argenio DZ; Covey JM; Eiseman JL
    Clin Cancer Res; 2006 Oct; 12(19):5826-33. PubMed ID: 17020990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine.
    Holleran JL; Parise RA; Joseph E; Eiseman JL; Covey JM; Glaze ER; Lyubimov AV; Chen YF; D'Argenio DZ; Egorin MJ
    Clin Cancer Res; 2005 May; 11(10):3862-8. PubMed ID: 15897587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Parise RA; Egorin MJ; Eiseman JL; Joseph E; Covey JM; Beumer JH
    Rapid Commun Mass Spectrom; 2007; 21(13):1991-7. PubMed ID: 17526067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay with UV detection for measurement of dihydrouracil/uracil ratio in plasma.
    Déporte R; Amiand M; Moreau A; Charbonnel C; Campion L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):170-7. PubMed ID: 16545990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
    Klecker RW; Cysyk RL; Collins JM
    Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.
    Peters GJ; van Groeningen CJ; Laurensse EJ; Lankelma J; Leyva A; Pinedo HM
    Cancer Chemother Pharmacol; 1987; 20(2):101-8. PubMed ID: 3664929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an ultra-high performance liquid chromatography tandem mass spectrometric method for quantifying uracil and 5,6-dihydrouracil in human plasma.
    Coudoré F; Roche D; Lefeuvre S; Faussot D; Billaud EM; Loriot MA; Beaune P
    J Chromatogr Sci; 2012; 50(10):877-84. PubMed ID: 22689904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved determination of uracil and dihydrouracil in plasma after a loading oral dose of uracil using high-performance liquid chromatography with photodiode array detection and porous graphitic carbon stationary phase.
    Hahn RZ; Galarza AF; Schneider A; Antunes MV; Schwartsmann G; Linden R
    Clin Biochem; 2015 Sep; 48(13-14):915-8. PubMed ID: 25940841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new sample preparation and separation combination for the precise, accurate, and simultaneous determination of uracil and dihydrouracil in human plasma by reversed-phase HPLC.
    Pan W; Li Y; Feng Y; Yang F; Liu H
    J Sep Sci; 2017 Oct; 40(19):3763-3770. PubMed ID: 28726286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).
    Beumer JH; Parise RA; Newman EM; Doroshow JH; Synold TW; Lenz HJ; Egorin MJ
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):363-8. PubMed ID: 17899082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An accurate dihydrouracil/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practice.
    Remaud G; Boisdron-Celle M; Hameline C; Morel A; Gamelin E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):98-107. PubMed ID: 16027050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients.
    Büchel B; Rhyn P; Schürch S; Bühr C; Amstutz U; Largiadèr CR
    Biomed Chromatogr; 2013 Jan; 27(1):7-16. PubMed ID: 22454320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracil.
    Mattison LK; Fourie J; Hirao Y; Koga T; Desmond RA; King JR; Shimizu T; Diasio RB
    Clin Cancer Res; 2006 Jan; 12(2):549-55. PubMed ID: 16428499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and simultaneous analysis of loxoprofen and its diastereometric alcohol metabolites in human serum by on-line column switching liquid chromatography and its application to a pharmacokinetic study.
    Cho HY; Park CH; Lee YB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):27-34. PubMed ID: 16563885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection.
    Wissen CP; Burger DM; Verweij PE; Aarnoutse RE; Brüggemann RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():79-84. PubMed ID: 22336695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells.
    Ben-Kasus T; Ben-Zvi Z; Marquez VE; Kelley JA; Agbaria R
    Biochem Pharmacol; 2005 Jul; 70(1):121-33. PubMed ID: 15885659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of gambogic acid in dog plasma by high-performance liquid chromatography for a pharmacokinetic study.
    Hao K; Zhao XP; Liu XQ; Wang GJ
    Biomed Chromatogr; 2007 Mar; 21(3):279-83. PubMed ID: 17221914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of the novel anticancer drug E7070 (indisulam) and its metabolite (1,4-benzenedisulphonamide) in human plasma, urine and faeces by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Beumer JH; Rosing H; Hillebrand MJ; Nan-Offeringa LG; Foley K; Yule SM; Heck AJ; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2004; 18(23):2839-48. PubMed ID: 15517526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase: relevance to chemotherapy.
    Ashour OM; Al Safarjalani ON; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
    Cancer Chemother Pharmacol; 2000; 45(5):351-61. PubMed ID: 10803917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.